# Candesartan

## Blopress 8mg

| TAH Drug Code      | [OBLO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OBLO)                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Heart failure， (NYHA class II to IV， ejection fraction 40% or less) to reduce cardiovascular mortality and hospitalizations. Hypertension.                                                                                              |
| Dosing             | HTN:initial: 8mg QD， may titrate up to 16mg， maximum 32mg.                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                  |
| Contraindications  | Concomitant use with aliskiren in diabetic patients. Hypersensitivity to candesartan. Severe hepatic impairment &/or cholestasis. Lactating women and women in the second and third trimesters of pregnancy. Children under one year old. |
| Adverse Effects    | Common Cardiovascular: Hypotension (18.8% ) Musculoskeletal: Backache (3% .) Neurologic: Dizziness (less than 5% ) Respiratory: Pharyngitis (2% )， Rhinitis (2% )， Upper respiratory infection (6% )                                    |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/candesartan-drug-information)                                                                                                                                                                |

